Data showed that fracture risk rises briefly after menopausal hormone therapy discontinuation, then falls below never-users.
Hannah Clarke
Advertisement
Articles by Hannah Clarke
Advertisement
Latest Updated Articles
Advertisement
Advertisement
- News
- Media
- Conferences
- Publications
- CME/CE
- Resources
- Subscribe
- About
- Partnerships
- Breast Health
- COVID-19
- Cervical Health
- Contraception
- Curbside Consults
- Dermatology
- Drug Pipeline News
- Endometriosis
- Genetic Testing
- Gynecology
- Imaging
- Infertility
- LARC
- Legally Speaking
- Life Transitions
- Malpractice
- Menopause
- Mental Health
- Noninvasive Prenatal Testing
- Obstetrics
- Opinion
- Osteoporosis
- Pediatrics
- Practice Management
- Pregnancy and Birth
- Sexual Health
- Sexually Transmitted Infections
- Surgery
- Technology
- Urology
- Uterine Fibroids
- Vulvovaginal Disease
- Well Woman
